| http://www.w3.org/ns/prov#value | - treatment repeated every three weeks.In another particular dosing schedule, a patient is given an infusion of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea or a salt thereof such as the lactate (particularly the L-lactate) or citrate salt as an IV bolus over 2 hour once a day for a week every 1, 2, or 3 weeks or over 2 hour once every 1, 2, or 3 weeks.Hig
|
